CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 

Live CME Meetings

Beginning Date

07/21/2014

Ending Date

01/24/2015

3.5

credits

3.5

contact hours

Target Audience

This activity has been designed to meet the educational needs of hepatologists, primary care providers, nurse practitioners/physician assistants, allied health care professionals, clinical pharmacists, and managed care decision makers.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Identify the risk factors and symptoms of chronic liver disease
  • Discuss laboratory tests and invasive/noninvasive methodologies used to ascertain the underlying cause and classify the stage of disease
  • Describe screening and treatment for patients with cirrhosis/hepatocellular carcinoma
  • Apply the AASLD guidelines on screening, diagnosis, and treatment of patients infected with chronic hepatitis C
  • Recognize the safety and efficacy of currently available HCV therapies and those expected in the next 6 months and advise patients regarding treatment options based on their individual characteristics


  • Physician Accreditation Statement

    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower, the Chronic Liver Disease Foundation (CLDF) and the International Coalition of Hepatology Education Providers (IC-Hep). The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

    The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Program #0797-9999-14-126-L04-P. This program is designated for up to 3.5 contact hours (0.35 CEUs) of continuing pharmacy education credit.

    Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    A maximum of 3.5 contact hours may be earned for successful completion of this activity.

    Provider is approved by the California Board of Registered Nursing, Provider # 13664, for 3.5 contact hours.

    Disclosure of Conflicts of Interest:

    All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enĀ¬during material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc.; John Bayliss, VP, Business Development, partner is an employee of Amgen, Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation have no relevant commercial relationships to disclose.

    Learner Assurance Statement:

    The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

    This is an invitation only. Submission of this form does not guarantee a seat at this meeting. Registration is confirmed on a first-come-first-served basis. Once your registration is processed, you will be notified regarding availability for this meeting.

    Americans with Disabilities Act

    The event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.). Please contact us prior to the event at 888-565-5321.

    Certified By:

    This activity endorsed by the International Coalition of Hepatology Educational Providers and sponsored by the Chronic Liver Disease Foundation.

    This activity Supported by:

    AbbVie, Bayer Health Care Pharmaceuticals, Bristol-Myers Squibb, Janssen Therapeutics and Onyx Pharmaceuticals.

    • Speaker
    • Date
    • Time
    • Venue/Location Information
    • W. Ray Kim, MD
      Aijaz Ahmed, MD
      Eugene Schiff, MD
    • Saturday 01/24/2015
    • 8:30 AM
    • Four Seasons Hotel
      East Palo Alto, CA
    • Register
     
                     
     
    HBV
    Webcasts
    Slide Library
    Abstract Library
     
    HE
    Live CME Meetings
    Webcasts
    Slide Library
    Abstract Library
     
    HCC
    Slide Library
    Abstract Library
     
     
    HCV
    Live CME Meetings
    Webcasts
    Slide Library
    Abstract Library
     
    CLDF Follow Us
       
     
    About CLDF
    Mission Statement
    Board of Trustees
    Board of Advisors
    CLDF Supporters
     
    Other Resources
    Liver News Library
    Journal Abstracts
    Hep C Link to Care
     
    Centers of
    Educational Expertise
    Regional Map
         
       
      The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
    © Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
    Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.